Alport syndrome: genes and variants
Explore variant evidence for Alport syndrome across 3 analyzed proteins (COL4A3, COL4A4, COL4A5). Linked ClinVar records include 199 pathogenic or likely pathogenic variants, 155 variants of uncertain significance and 161 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Alport syndrome
COL4A3: Collagen alpha-3(IV) chain
It contributes to the alpha3-alpha4-alpha5 type IV collagen network that forms the specialized basement membrane of the renal glomerulus, cochlea, and eye. Pathogenic variants cause Alport-spectrum disease and thin-basement-membrane nephropathy, with variable kidney and hearing involvement.
128 ClinVar pathogenic / likely pathogenic and 216 uncertain variants in COL4A3 have source records linked to Alport syndrome. Association strength is not clinical gene validity.
COL4A4: Collagen alpha-4(IV) chain
It combines with the alpha3 and alpha5 chains to form the mature type IV collagen network of glomerular, cochlear, and ocular basement membranes. Pathogenic variants cause autosomal Alport-spectrum disease and can present with isolated persistent hematuria.
57 ClinVar pathogenic / likely pathogenic and 97 uncertain variants in COL4A4 have source records linked to Alport syndrome. Association strength is not clinical gene validity.
COL4A5: Collagen alpha-5(IV) chain
It is essential for the alpha3-alpha4-alpha5 type IV collagen network that gives glomerular and cochlear basement membranes their mature mechanical properties. Pathogenic variants cause X-linked Alport syndrome, with progressive kidney disease, hearing loss, and characteristic ocular findings.
14 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in COL4A5 have source records linked to Alport syndrome. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): CLDN14 and MYO15A.
ClinVar pathogenic and likely pathogenic variants linked to Alport syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| COL4A3 G230D | 230 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G230V | 230 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G532C | 532 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G532D | 532 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G563R | 563 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G801R | 801 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G922V | 922 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G922R | 922 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G922E | 922 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G955R | 955 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1080R | 1080 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1198D | 1198 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1198S | 1198 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G475C | 475 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G475A | 475 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G792E | 792 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G870R | 870 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G1264V | 1264 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G631V | 631 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G91D | 91 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G230S | 230 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G318D | 318 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G452R | 452 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G458R | 458 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G493R | 493 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G520D | 520 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G637R | 637 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G712V | 712 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G715S | 715 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G759R | 759 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G777D | 777 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G783R | 783 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G795E | 795 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G827R | 827 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G883R | 883 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G889V | 889 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1137D | 1137 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1152S | 1152 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1189E | 1189 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1207R | 1207 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1228D | 1228 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1322C | 1322 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1337E | 1337 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G1385E | 1385 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G98D | 98 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G143V | 143 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G305V | 305 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G478E | 478 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G551D | 551 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G572A | 572 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G695D | 695 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G792R | 792 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G855R | 855 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G870S | 870 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G1066V | 1066 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A4 G1091R | 1091 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G230V | 230 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A5 G1030S | 1030 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G148V | 148 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL4A3 G227E | 227 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
Showing 60 of 199.
Uncertain variants prioritized for review in Alport syndrome
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| COL4A4 G1066R | 1066 | Triple-helical region | Conflicting reports (★) | +7: G1066V at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.990 |
| COL4A3 G1164D | 1164 | Triple-helical region | Conflicting reports (★) | +7: 2 other pathogenic changes within 3 positions; G1164C at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.986 |
| COL4A3 G662E | 662 | Triple-helical region | Conflicting reports (★) | +7: 2 other pathogenic changes within 3 positions; G662R at the same position is pathogenic; seen in 1.4e-06 of gnomAD DNA copies; REVEL 0.932 |
| COL4A3 G985V | 985 | Triple-helical region | Conflicting reports (★) | +7: 3 other pathogenic changes within 3 positions; G985E at the same position is pathogenic; seen in 4.1e-06 of gnomAD DNA copies; REVEL 0.951 |
| COL4A3 G1083R | 1083 | Triple-helical region | Conflicting reports (★) | +6: 5 other pathogenic changes within 3 positions; G1083E at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.82 |
| COL4A4 G113D | 113 | Triple-helical region | Conflicting reports (★) | +6: G113C at the same position is pathogenic; REVEL 0.959 |
Which prediction tools work for Alport syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- REVEL: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 99 out of 100
- phyloP: 99 out of 100
- MetaLR: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 98 out of 100
- MutPred: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- EVE: 98 out of 100
- SIFT: 96 out of 100
- MetaSVM: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 95 out of 100
- Pangolin: 55 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 53 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Autosomal dominant Alport syndrome also has ClinVar records linked to COL4A3 variants; they fall partly in the same places as the Alport syndrome variants (131 pathogenic / likely pathogenic).
- Benign familial hematuria also has ClinVar records linked to COL4A3 variants; they fall partly in the same places as the Alport syndrome variants (76 pathogenic / likely pathogenic).
- Autosomal recessive Alport syndrome also has ClinVar records linked to COL4A3 variants; they fall partly in the same places as the Alport syndrome variants (32 pathogenic / likely pathogenic).
- Autosomal recessive Alport syndrome also has ClinVar records linked to COL4A4 variants; they fall mostly in different places as the Alport syndrome variants (99 pathogenic / likely pathogenic).
- Benign familial hematuria also has ClinVar records linked to COL4A4 variants; they fall partly in the same places as the Alport syndrome variants (65 pathogenic / likely pathogenic).
- Autosomal dominant Alport syndrome also has ClinVar records linked to COL4A4 variants; they fall mostly in different places as the Alport syndrome variants (6 pathogenic / likely pathogenic).
- X-linked Alport syndrome also has ClinVar records linked to COL4A5 variants; they fall mostly in different places as the Alport syndrome variants (341 pathogenic / likely pathogenic).
Diseases related to Alport syndrome
- Autosomal dominant Alport syndrome, also linked to COL4A3, COL4A4 and COL4A5
- Benign familial hematuria, also linked to COL4A3 and COL4A4
- Autosomal recessive Alport syndrome, also linked to COL4A3 and COL4A4
- Nephrotic syndrome, also linked to COL4A4 and COL4A5
- Benign neonatal seizures, also linked to COL4A3 and COL4A4
- Kidney disorder, also linked to COL4A3 and COL4A5
- X-linked Alport syndrome, also linked to COL4A5
- Rare genetic deafness, also linked to COL4A5
- Polycystic kidney disease, also linked to COL4A4
- Monogenic hearing loss, also linked to COL4A5
- Steroid-resistant nephrotic syndrome, also linked to COL4A5
- Isolated macular dystrophy, also linked to COL4A5
Frequently asked questions
Which genes have records linked to Alport syndrome?
This view contains 3 analyzed proteins: COL4A3, COL4A4, COL4A5. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 199 pathogenic or likely pathogenic variants, 155 variants of uncertain significance and 161 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 6 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 576 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center